TW224053B - - Google Patents

Info

Publication number
TW224053B
TW224053B TW081101971A TW81101971A TW224053B TW 224053 B TW224053 B TW 224053B TW 081101971 A TW081101971 A TW 081101971A TW 81101971 A TW81101971 A TW 81101971A TW 224053 B TW224053 B TW 224053B
Authority
TW
Taiwan
Prior art keywords
thymosin
immune system
potentiating
pref
fragment
Prior art date
Application number
TW081101971A
Other languages
English (en)
Chinese (zh)
Original Assignee
Paul B Chretien
Milton G Mutchnick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul B Chretien, Milton G Mutchnick filed Critical Paul B Chretien
Application granted granted Critical
Publication of TW224053B publication Critical patent/TW224053B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
TW081101971A 1991-09-13 1992-03-16 TW224053B (US07384924-20080610-C00104.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75954491A 1991-09-13 1991-09-13

Publications (1)

Publication Number Publication Date
TW224053B true TW224053B (US07384924-20080610-C00104.png) 1994-05-21

Family

ID=25056052

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081101971A TW224053B (US07384924-20080610-C00104.png) 1991-09-13 1992-03-16

Country Status (23)

Country Link
US (3) US6001799A (US07384924-20080610-C00104.png)
EP (1) EP0603305B1 (US07384924-20080610-C00104.png)
JP (1) JP3228512B2 (US07384924-20080610-C00104.png)
KR (1) KR100254082B1 (US07384924-20080610-C00104.png)
AT (1) ATE152914T1 (US07384924-20080610-C00104.png)
AU (1) AU667327B2 (US07384924-20080610-C00104.png)
CA (1) CA2119006C (US07384924-20080610-C00104.png)
CZ (1) CZ286827B6 (US07384924-20080610-C00104.png)
DE (1) DE69219782T2 (US07384924-20080610-C00104.png)
DK (1) DK0603305T3 (US07384924-20080610-C00104.png)
ES (1) ES2103966T3 (US07384924-20080610-C00104.png)
FI (1) FI107879B (US07384924-20080610-C00104.png)
GR (1) GR3024025T3 (US07384924-20080610-C00104.png)
HK (1) HK1021687A1 (US07384924-20080610-C00104.png)
HU (1) HU221006B1 (US07384924-20080610-C00104.png)
MX (1) MX9205240A (US07384924-20080610-C00104.png)
NO (1) NO941310L (US07384924-20080610-C00104.png)
RO (1) RO111991B1 (US07384924-20080610-C00104.png)
RU (1) RU2104010C1 (US07384924-20080610-C00104.png)
SG (1) SG64897A1 (US07384924-20080610-C00104.png)
TW (1) TW224053B (US07384924-20080610-C00104.png)
WO (1) WO1993005806A1 (US07384924-20080610-C00104.png)
ZA (1) ZA926964B (US07384924-20080610-C00104.png)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (US07384924-20080610-C00104.png) * 1991-09-13 1994-05-21 Paul B Chretien
EP0728010A4 (en) * 1992-02-06 1997-10-01 Sciclone Pharmaceuticals METHOD FOR TREATING HEPATITIS B CARRIERS WITH A MINOR DISEASE
AU751199B2 (en) * 1992-07-13 2002-08-08 Government Of The United States Of America As Represented By The Secretary Of The Army Composition and method of treating hepatitis B
AU4671193A (en) * 1992-07-13 1994-01-31 Kenneth E. Sherman Composition and method of treating hepatitis b
CN1072961C (zh) * 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
US6200952B1 (en) * 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5468729A (en) * 1993-10-26 1995-11-21 Alpha 1 Biomedicals Method for treatment of autoimmune hepatitis
PT731710E (pt) * 1993-11-05 2003-09-30 Sciclone Pharmaceuticals Inc Composicoes contendo timosine alpha 1 destinadas ao tratamento de pacientes sofrendo duma doenca de figado descompensado
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
WO1997031649A1 (en) * 1996-02-28 1997-09-04 Ifi Istituto Farmacoterapico Italiano S.P.A. PHARMACEUTICAL COMPOSITIONS COMPRISING NATURAL HUMAN α-INTERFERON
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
US7208167B2 (en) * 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
ATE348628T1 (de) * 2000-08-07 2007-01-15 Sciclone Pharmaceuticals Inc Behandlung von hepatitis c mit thymosin, interferon und ribavirin
WO2002044717A1 (en) * 2000-12-01 2002-06-06 Cornell Research Foundation Animal model for flaviviridae infection
JP2005504087A (ja) * 2001-09-28 2005-02-10 イデニクス（ケイマン）リミテツド ４’が修飾されたヌクレオシドを使用するｃ型肝炎ウイルス治療のための方法および組成物
US20050013801A1 (en) * 2001-10-05 2005-01-20 Hsu Henry H. Methods of treating liver fibrosis and hepatitis c virus infection
EP1448223B1 (en) * 2001-10-26 2008-01-02 Rhode Island Hospital Thymosin augmentation of genetic immunization
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
WO2003068162A2 (en) * 2002-02-14 2003-08-21 Pharmasset Ltd. Modified fluorinated nucleoside analogues
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
JP2005533817A (ja) 2002-06-28 2005-11-10 イデニクス（ケイマン）リミテツド フラビウィルス科ウィルス感染治療用の修飾２′および３′−ヌクレオシドプロドラッグ
BR0312278A (pt) 2002-06-28 2007-06-19 Idenix Cayman Ltd éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
EP1576138B1 (en) 2002-11-15 2017-02-01 Idenix Pharmaceuticals LLC. 2'-methyl nucleosides in combination with interferon and flaviviridae mutation
AU2003300901A1 (en) 2002-12-12 2004-06-30 Idenix (Cayman) Limited Process for the production of 2'-branched nucleosides
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
JP4149296B2 (ja) * 2003-03-26 2008-09-10 株式会社ルネサステクノロジ 半導体記憶装置
EP1613340B1 (en) * 2003-03-28 2010-05-12 SciClone Pharmaceuticals, Inc. Treatment of aspergillus infections with thymosin alpha 1
CN100342907C (zh) * 2003-03-28 2007-10-17 希克龙制药公司 胸腺素α1在制备用于治疗或预防哺乳动物中曲霉菌感染的药物组合物中的应用
US20100311656A1 (en) * 2003-04-23 2010-12-09 Sciclone Pharmaceuticals, Inc. Treatment or prevention of respiratory viral infections with alpha thymosin peptides
ES2726998T3 (es) 2003-05-30 2019-10-11 Gilead Pharmasset Llc Análogos de nucleósidos fluorados modificados
BRPI0412849A (pt) 2003-07-25 2006-09-26 Idenix Cayman Ltd compostos, composições e usos de análogos de nucleosìdeo de purina para o tratamento de flaviviridae, incluindo hepatite c
WO2005021007A1 (fr) * 2003-08-28 2005-03-10 Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' Prevention et traitement de l'hepatite virale b
US7754718B2 (en) 2004-05-05 2010-07-13 Yale University Antiviral helioxanthin analogs
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
PT3109244T (pt) 2004-09-14 2019-06-04 Gilead Pharmasset Llc ¿preparação de ribofuranosil pirimidinas e purinas 2¿-fluoro-2¿-alquil substituídas ou outras opcionalmente substituídas e os seus derivados
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
ES2389452T3 (es) * 2006-05-02 2012-10-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de timosina 1, sola o en combinación con PTX3 o ganciclovir, para el tratamiento de infección por citomegalovirus
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) * 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US20110195048A1 (en) * 2008-10-08 2011-08-11 Podack Eckhard R Regulation of lymphocytes and uses therefor
BRPI0922508A8 (pt) 2008-12-23 2016-01-19 Pharmasset Inc Análogos de nucleosídeo
CA2748057C (en) 2008-12-23 2018-07-03 Pharmasset, Inc. Nucleoside phosphoramidates
JP5793084B2 (ja) 2008-12-23 2015-10-14 ギリアド ファーマセット エルエルシー プリンヌクレオシドの合成
JP2012526149A (ja) 2009-05-08 2012-10-25 サイクローン・ファーマシューティカルズ・インコーポレイテッド ワクチン増強剤としてのαチモシンペプチド
TWI598358B (zh) 2009-05-20 2017-09-11 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN102858790A (zh) 2010-03-31 2013-01-02 吉利德制药有限责任公司 核苷氨基磷酸酯
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
PT3042910T (pt) 2010-11-30 2019-04-16 Gilead Pharmasset Llc 2'-espiro-nucleósidos para utilização na terapia da hepatite c
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US8809354B2 (en) 2011-12-31 2014-08-19 Sheikh Riazuddin 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
CN103800293B (zh) * 2012-11-09 2015-10-21 长春海悦药业有限公司 一种含有胸腺法新的药物组合物及其制剂
MX2016002185A (es) 2013-08-27 2016-06-06 Gilead Pharmasset Llc Formulacion combinada de dos compuestos antivirales.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
TW224053B (US07384924-20080610-C00104.png) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
MX9205240A (es) 1993-07-01
HU221006B1 (hu) 2002-07-29
WO1993005806A1 (en) 1993-04-01
RU2104010C1 (ru) 1998-02-10
GR3024025T3 (en) 1997-10-31
EP0603305A1 (en) 1994-06-29
DE69219782T2 (de) 1997-10-09
SG64897A1 (en) 1999-05-25
EP0603305B1 (en) 1997-05-14
RU94022480A (ru) 1996-07-20
CZ55194A3 (en) 1994-10-19
DK0603305T3 (da) 1997-09-01
JP3228512B2 (ja) 2001-11-12
AU667327B2 (en) 1996-03-21
HK1021687A1 (en) 2000-06-23
ES2103966T3 (es) 1997-10-01
FI941133A0 (fi) 1994-03-10
ATE152914T1 (de) 1997-05-15
FI941133A (fi) 1994-03-10
NO941310D0 (no) 1994-04-12
HU9400758D0 (en) 1994-06-28
US6001799A (en) 1999-12-14
US20070218033A1 (en) 2007-09-20
CA2119006C (en) 2005-08-23
HUT75166A (en) 1997-04-28
US5849696A (en) 1998-12-15
AU2644792A (en) 1993-04-27
FI107879B (fi) 2001-10-31
KR100254082B1 (ko) 2000-09-01
CZ286827B6 (cs) 2000-07-12
CA2119006A1 (en) 1993-04-01
ZA926964B (en) 1993-04-26
NO941310L (no) 1994-04-12
JPH06510998A (ja) 1994-12-08
DE69219782D1 (de) 1997-06-19
RO111991B1 (ro) 1997-04-30

Similar Documents

Publication Publication Date Title
TW224053B (US07384924-20080610-C00104.png)
EP0605442A4 (en) RECOMBINANT ANTIBODIES FOR HUMAN THERAPY.
EP0599209A3 (en) Process for the fractionation of a polyhydrogensilsesquioxane according to its molecular weight.
AU3022692A (en) Methods for the treatment of osteoporosis using bone-active phosphonates and parathyroid hormone
EP0528869A4 (en) PROCESS FOR TREATING A LESIONED ARTERIAL WALL DURING ANGIOPLASTY.
IT1267448B1 (it) Vaccino per la prevenzione della sindrome riproduttiva e respiratoria porcina.
EP0717592A4 (en) METHOD AND COMPOSITION FOR TREATING THE APATHIE DEMOTIVATION SYNDROME
GR3006630T3 (US07384924-20080610-C00104.png)
EP0596962A4 (en) Therapeutic compositions and methods.
ZA921107B (en) Method of treating Type I diabetes.
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
AU3689193A (en) Method of treating osteoporosis with 1 alpha, 24 (R)-dihydroxy-22 (E)-dehydro-vitamin D3
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
GB9208673D0 (en) Ionised vapour source
GB2271509A8 (en) Antivenom immunesera
EP0648124A4 (en) METHOD FOR STIMULATING THE IMMUNE SYSTEM.
EP0235904A3 (en) Treatment of allergy with thymopentin
EP0609335A4 (en) Methods for the treatment of hyperlipidemia using azaspiranes.
AU6060694A (en) Method for treating acquired immune deficiency syndrome
AU4754993A (en) Method for the immunochemical quantificaiton of inactivated, immunoreactive antigens
ZA924552B (en) Gas injection apparatus and method.
EP0599840A4 (en) Catheters and valve for endotracheal suctioning.
ZA929418B (en) Recombinant vaccines and method of producing same.
UA27795C2 (uk) Спосіб виведення радіонуклідів із організму
IT213831Z2 (it) Dispositivo di bloccaggio per rotelle di poltrone scrivanie esimili.